Spot on Lung CT: Nodule Detection and What's Next

A "spot on the lung" found on an X-ray or CT scan is one of the most common incidental imaging findings — appearing on roughly 30% of chest CTs. Most are benign. Some are early lung cancer. This light guide explains what counts as a spot, what makes one suspicious, and the workup pathway.

What Counts as a "Spot"

The medical term is "pulmonary nodule." Definitions:

• Nodule: a discrete round opacity <3 cm
• Mass: a discrete round opacity ≥3 cm
• Solitary: only one nodule visible
• Multiple: more than one
• Solid, part-solid, or pure ground-glass: different textures with different risk

A "spot" is usually a nodule. A "shadow" or "haziness" is less specific and may need diagnostic CT to characterize.

Size and Malignancy Risk

Malignancy risk in solid pulmonary nodules:

Diameter	Approximate malignancy risk
<4 mm	<0.1%
4-6 mm	0.5-1%
6-8 mm	0.7-2.5%
8-15 mm	5-15%
15-30 mm	20-40%
>30 mm (mass)	>50%

Risk roughly doubles per 5 mm in the small-nodule range. Risk shifts upward in high-risk patients (smokers, family history, emphysema).

Texture: Solid vs Subsolid vs Ground-Glass

Three textures with different timelines:

• Solid nodules: standard size-risk curve above applies
• Part-solid (subsolid with solid component): highest cancer risk per mm
• Pure ground-glass nodules: slowest progression; often adenocarcinoma in situ

A 20 mm pure ground-glass may have <10% short-term malignancy risk but warrants long-term follow-up because adenocarcinoma in situ presents this way.

Lung-RADS Classification

The American College of Radiology system categorizes findings:

• Category 1: negative findings; annual LDCT
• Category 2: benign appearance; annual LDCT
• Category 3: probably benign; 6-month follow-up
• Category 4A: suspicious; 3-month follow-up or PET-CT
• Category 4B: very suspicious; PET-CT and consider biopsy
• Category 4X: highly suspicious; treat as cancer until proven otherwise

A clean LDCT report ending with "Lung-RADS 1" or "2" is reassuring.

Follow-Up Workup

For nodules requiring follow-up:

Action	When
Repeat LDCT in 12 months	<6 mm in low-risk patient
Repeat LDCT in 6 months	6-8 mm, or 4-6 mm new
Repeat LDCT in 3 months OR PET-CT	8-15 mm or growing
Biopsy or surgical resection	>15 mm with suspicious features
Immediate workup	>30 mm or any spiculated/highly suspicious nodule

For workup of an indeterminate lung nodule, our team can help.

When PET-CT Helps and When It Doesn't

PET-CT is useful for nodules 8 mm or larger. Below that size:

• PET resolution limit is ~5 mm
• Partial volume effects underestimate SUV
• LDCT follow-up is preferred

Above 8 mm:
- SUVmax >2.5 suggests malignancy
- SUVmax <2.5 doesn't rule it out (especially for subsolid or ground-glass)
- Tissue confirmation is the definitive test

Biopsy Options

When tissue diagnosis is needed:

• CT-guided percutaneous biopsy: peripheral lesions; 85-90% sensitivity; 15-25% pneumothorax rate
• Bronchoscopy with biopsy: central or endobronchial lesions
• EBUS-TBNA: mediastinal lymph node sampling
• Surgical biopsy (VATS): indeterminate or surgical candidates

Cost: $4,000-9,000 US for percutaneous biopsy; ¥6,000-12,000 China.

Frequently Asked Questions

My report says "4 mm nodule, no follow-up needed." Should I worry?
For solid nodules under 6 mm in low-risk patients, no follow-up is the standard. If you have heavy smoking history or family lung cancer, mention this — annual LDCT may still be sensible.

The nodule is the same size at one year. Am I safe?
Stability over 2 years (solid) or 5 years (subsolid) is the conventional definition of benign. One year is reassuring but not yet conclusive.

Can a benign nodule grow?
Granulomas (old TB scars), benign tumors, and inflammatory nodules can change size. Growth alone doesn't prove cancer — context and rate of change matter.

Should I get a second-opinion read?
For indeterminate findings without clear recommendations, yes. International teleradiology second opinion at top Chinese centers costs ¥1,000-2,500.

Need Help Booking?

SinoCareLink can pre-book LDCT follow-up, PET-CT, or biopsy at a top Chinese hospital, coordinate pathology review, translate reports into English, and arrange airport pickup. Contact us for a free consultation.